SEC Form 4 · accession 0001209191-16-113552
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Vasavada
Officer — VP Research and Development
Period of report
Apr 4, 2016
Accepted (ET)
Apr 6, 2016 · 8:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.9331 | Apr 4, 2016 | A | 20,000 | A | — | Apr 4, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option vests with respect to 1/4 of the total shares subject to the option on the first anniversary of the vesting commencement date of April 4, 2016, and with respect to 1/48 of the total shares subject to the option monthly thereafter for 36 months.